188 related articles for article (PubMed ID: 10048421)
1. Thrombosis related to the use of L-asparaginase in adults with acute lymphoblastic leukemia: a need to consider coagulation monitoring and clotting factor replacement.
Alberts SR; Bretscher M; Wiltsie JC; O'Neill BP; Mokri B; Witzig TE
Leuk Lymphoma; 1999 Feb; 32(5-6):489-96. PubMed ID: 10048421
[TBL] [Abstract][Full Text] [Related]
2. Cerebral venous thrombosis in adult patients with acute lymphoblastic leukemia or lymphoblastic lymphoma during induction chemotherapy with l-asparaginase: The GRAALL experience.
Couturier MA; Huguet F; Chevallier P; Suarez F; Thomas X; Escoffre-Barbe M; Cacheux V; Pignon JM; Bonmati C; Sanhes L; Bories P; Daguindau E; Dorvaux V; Reman O; Frayfer J; Orvain C; Lhéritier V; Ifrah N; Dombret H; Hunault-Berger M; Tanguy-Schmidt A
Am J Hematol; 2015 Nov; 90(11):986-91. PubMed ID: 26214580
[TBL] [Abstract][Full Text] [Related]
3. The coagulopathy and thrombotic risk associated with L-asparaginase treatment in adults with acute lymphoblastic leukaemia.
Truelove E; Fielding AK; Hunt BJ
Leukemia; 2013 Mar; 27(3):553-9. PubMed ID: 23099335
[TBL] [Abstract][Full Text] [Related]
4. Chemotherapy induces enhanced procoagulant activity through phosphatidylserine exposure in acute lymphoblastic leukemia.
Dong X; Shi J; Zhou J; Chen X; Jin Y; Zhang X; Li X; Dai H; Wang J
Thromb Res; 2013 Nov; 132(5):614-20. PubMed ID: 24074703
[TBL] [Abstract][Full Text] [Related]
5. An antithrombin replacement strategy during asparaginase therapy for acute lymphoblastic leukemia is associated with a reduction in thrombotic events.
Farrell K; Fyfe A; Allan J; Tait RC; Leach M
Leuk Lymphoma; 2016 Nov; 57(11):2568-74. PubMed ID: 27078747
[TBL] [Abstract][Full Text] [Related]
6. Incidence of asparaginase-related hepatotoxicity, pancreatitis, and thrombotic events in adults with acute lymphoblastic leukemia treated with a pediatric-inspired regimen.
Christ TN; Stock W; Knoebel RW
J Oncol Pharm Pract; 2018 Jun; 24(4):299-308. PubMed ID: 28355969
[TBL] [Abstract][Full Text] [Related]
7. Sequelae of thrombotic or hemorrhagic complications following L-asparaginase therapy for childhood lymphoblastic leukemia.
Ott N; Ramsay NK; Priest JR; Lipton M; Pui CH; Steinherz P; Nesbit ME
Am J Pediatr Hematol Oncol; 1988; 10(3):191-5. PubMed ID: 3177809
[TBL] [Abstract][Full Text] [Related]
8. A prospective cohort study determining the prevalence of thrombotic events in children with acute lymphoblastic leukemia and a central venous line who are treated with L-asparaginase: results of the Prophylactic Antithrombin Replacement in Kids with Acute Lymphoblastic Leukemia Treated with Asparaginase (PARKAA) Study.
Mitchell LG; Andrew M; Hanna K; Abshire T; Halton J; Anderson R; Cherrick I; Desai S; Mahoney D; McCuster P; Wu J; Dahl G; Chait P; de Veber G; Lee KJ; Mikulis D; Ginsberg J; Way C;
Cancer; 2003 Jan; 97(2):508-16. PubMed ID: 12518376
[TBL] [Abstract][Full Text] [Related]
9. Different profile of thrombin generation in children with acute lymphoblastic leukaemia treated with native or pegylated asparaginase: A cohort study.
Rozen L; Noubouossie D; Dedeken L; Huybrechts S; Lê PQ; Ferster A; Demulder A
Pediatr Blood Cancer; 2017 Feb; 64(2):294-301. PubMed ID: 27605400
[TBL] [Abstract][Full Text] [Related]
10. Thrombosis associated with L-asparaginase therapy and low fibrinogen levels in adult acute lymphoblastic leukemia.
Beinart G; Damon L
Am J Hematol; 2004 Dec; 77(4):331-5. PubMed ID: 15551293
[TBL] [Abstract][Full Text] [Related]
11. Management of L-asparaginase induced prothrombotic state in acute lymphoblastic leukemia.
Parma M; Belotti D; Pogliani EM
Haematologica; 1996; 81(2):191. PubMed ID: 8641657
[No Abstract] [Full Text] [Related]
12. Minimal effects of E. coli and Erwinia asparaginase on the coagulation system in childhood acute lymphoblastic leukemia: a randomized study.
Risseeuw-Appel IM; Dekker I; Hop WC; Hählen K
Med Pediatr Oncol; 1994; 23(4):335-43. PubMed ID: 8058004
[TBL] [Abstract][Full Text] [Related]
13. Venous thromboembolism following L-asparaginase treatment for lymphoid malignancies in Korea.
Lee JH; Lee J; Yhim HY; Oh D; Bang SM
J Thromb Haemost; 2017 Apr; 15(4):655-661. PubMed ID: 28150907
[TBL] [Abstract][Full Text] [Related]
14. Use of L-asparaginase in acute lymphoblastic leukemia: recommendations of the Polish Adult Leukemia Group.
Piatkowska-Jakubas B; Krawczyk-Kuliś M; Giebel S; Adamczyk-Cioch M; Czyz A; Lech Marańda E; Paluszewska M; Pałynyczko G; Piszcz J; Hołowiecki J;
Pol Arch Med Wewn; 2008 Nov; 118(11):664-9. PubMed ID: 19140571
[TBL] [Abstract][Full Text] [Related]
15. L-asparaginase-induced posterior reversible encephalopathy syndrome during acute lymphoblastic leukemia treatment in children.
Hourani R; Abboud M; Hourani M; Khalifeh H; Muwakkit S
Neuropediatrics; 2008 Feb; 39(1):46-50. PubMed ID: 18504683
[TBL] [Abstract][Full Text] [Related]
16. Effects of Erwinia-asparaginase on the coagulation system.
Carlsson H; Stockelberg D; Tengborn L; Braide I; Carneskog J; Kutti J
Eur J Haematol; 1995 Nov; 55(5):289-93. PubMed ID: 7493674
[TBL] [Abstract][Full Text] [Related]
17. L-asparaginase induced hypoglycemia in a case of acute lymphoblastic leukemia: a patient report.
Misgar RA; Laway BA; Rahaman SH; Wani AI; Bashir MI; Bhat JR
J Pediatr Endocrinol Metab; 2015 Mar; 28(3-4):439-41. PubMed ID: 25210761
[TBL] [Abstract][Full Text] [Related]
18. [Influence of L-asaraginase and Pegaspargase on Coagulation Function of Adult Patients with Acute Lymphoblastic Leukemia and Analysis of Related Factors].
Xu LW; Wei XL; Wei YQ; Hao XX; Zhou QJ; Feng R
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Feb; 24(1):30-5. PubMed ID: 26913389
[TBL] [Abstract][Full Text] [Related]
19. A Young Boy with L-asparaginase-Induced Seizure.
Aziz MA; Singh NK; Rahman MH; Khan MR; Kabir AL; Begum M
Mymensingh Med J; 2017 Apr; 26(2):459-461. PubMed ID: 28588188
[TBL] [Abstract][Full Text] [Related]
20. Low plasma levels of hemostatic proteins during the induction phase in children with acute lymphoblastic leukemia: A retrospective study by the JACLS. Japan Association of Childhood Leukemia Study.
Hongo T; Okada S; Ohzeki T; Ohta H; Nishimura S; Hamamoto K; Yagi K; Misu H; Eguchi N; Suzuki N; Horibe K; Ueda K
Pediatr Int; 2002 Jun; 44(3):293-9. PubMed ID: 11982900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
